Diligence memo · auto-generated · as of July 2, 2026
Fresenius Vascular Care Culver City MSO, LLC
Fresenius Vascular Care Culver City MSO, LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Fresenius Vascular Care Culver City MSO, LLC operates in Other Health Care, based in WALTHAM.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Fresenius Vascular Care Culver City MSO, LLC has raised $11M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $11M on 2014-04-07.
Most recent recorded round closed around 2014-04-07.
Valuation (modeled)modeled
Provath models Fresenius Vascular Care Culver City MSO, LLC at approximately $220M (range $14M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.82× the median modeled value of Series A Other Health Care companies in 2013–2015 (187 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 12.2 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 77% of Other Health Care peers (5377 compared).
Modeled value ranks above 88% of those peers.
Closest niche peers: Imagine Health, Inc., Spruce Health, Inc., Inova Labs, Inc., Cephea Valve Technologies, Inc., ClarVista Medical, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.